Skip to content

News & Press

Avicanna Hosts Symposium on Cannabinoid-based Medicine

29 February 2024

Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company

15 February 2024

Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™

13 February 2024

Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company

5 February 2024

Avicanna and Ease Labs Pharma Granted Commercialization Approval for Pharmaceutical Preparation in Brazil

30 January 2024

Avicanna Announces Closing of Non-Brokered Private Placement

4 December 2023
« Prev1234567Next »